Advisor Group’s Allergan plc AGN.PRA Stock Holding History

Advisor Group’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-347	Closed	-$204K	–	5205
2017 Q4	$204K	Buy	347 +24	+7%	+$15.5K	﹤0.01%	1990
2017 Q3	$238K	Buy	323 +1	+0.3%	+$830	﹤0.01%	1724
2017 Q2	$280K	Sell	322 -31	-9%	-$26K	﹤0.01%	1528
2017 Q1	$300K	Buy	353 +30	+9%	+$24.9K	0.01%	1383
2016 Q4	$247K	Buy	323 +60	+23%	+$45.3K	0.01%	1418
2016 Q3	$216K	Buy	263 +8	+3%	+$6.92K	0.01%	1473
2016 Q2	$211K	Buy	+255	New	+$213K	0.01%	1434

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Advisor Group's AGN.PRA Position: Q1 2018 in Review

Advisor Group sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 347 shares — an estimated $204K sold.

Advisor Group first reported a position in AGN.PRA in Q2 2016 and held it in 7 quarters. The position peaked at $300K in Q1 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Advisor Group reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Advisor Group sold 347 Allergan plc shares in Q1 2018, an estimated $204K.
Advisor Group first reported a position in Allergan plc in Q2 2016 and held it in 7 quarters.
Advisor Group's Allergan plc position peaked at $300K in Q1 2017.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Advisor Group's 13F filing for Q1 2018, filed 15 May 2018.